Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vermont's Prescriber Data Law Faces Tough Questions In Appeals Court

This article was originally published in The Pink Sheet Daily

Executive Summary

Second Circuit hears oral arguments in IMS Health suit challenging the statute, which limits the sale of physician prescribing information; judge asks if leveling the playing field of ideas is constitutional basis for legislation.

You may also be interested in...



Data Mining Could End Up At Supreme Court After Second Circuit Ruling On Vermont Law

Appeals court says the state could pursue alternative measures to contain healthcare costs, such as academic detailing and mandating generic drugs for patients receiving Medicare Part D funds.

Data Mining Could End Up At Supreme Court After Second Circuit Ruling On Vermont Law

Appeals court says the state could pursue alternative measures to contain healthcare costs, such as academic detailing and mandating generic drugs for patients receiving Medicare Part D funds.

Pharma Industry Watchdog Brill Nominated For FTC Commissioner

Julie Brill, who has had a long-standing interest in pharmaceutical industry pricing and marketing practices, has been nominated to be one of the five commissioners of the Federal Trade Commission

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS068594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel